<DOC>
	<DOCNO>NCT02863107</DOCNO>
	<brief_summary>The goal laboratory research study learn genetic factor may influence risk develop colorectal cancer young age .</brief_summary>
	<brief_title>Young-Onset Microsatellite-Stable Colorectal Cancer</brief_title>
	<detailed_description>Questionnaires : If participant agrees take part study , fill questionnaire work , family history , medical history , health habit . It take 10-15 minute complete questionnaire . Participant complete another questionnaire experience cancer survivor . These question participant 's quality life , well-being , concern may , well type health care follow-up care receive . It take 20-25 minute complete questionnaire . All questionnaires either give participant research staff one MD Anderson visit mail participant 's home postage-paid return envelope mail back study staff . Blood Saliva Collection : Blood ( 2 tablespoon ) collect 1 time . If participant unwilling unable give blood sample , saliva sample collect instead . While participant MD Anderson , saliva collection kit give . Length Study : If participant active patient undergone treatment MD Anderson Cancer Center within past year , receive additional questionnaire 6 12 month complete treatment , every year 5 year . If participant patient complete treatment 1 year ago , patient , also complete questionnaire least every year 5 year . This investigational study . Up 1,000 patient family member take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>1 . MDACC patient adenocarcinoma colon rectum , diagnose age 18 50 ( youngonset ) , diagnose age 65 older ( lateronset ) , microsatellite status testing ( either immunohistochemistry PCR test germline test combination thereof ) . 2 . Patient must sufficient command English language mental capacity provide consent . 1 . Patient must NOT know suspected clinical diagnosis hereditary polyposis syndrome include hereditary adenomatous polyposis syndrome , hereditary nonadenomatous polyposis syndrome , hereditary nonpolyposis syndrome . 2 . Patient 's adenocarcinoma must NOT microsatellite high unstable ( defined loss expression least one DNA mismatch repair gene MLH1 , MSH2 , MSH6 , PMS2 immunohistochemistry , and/or &gt; 30 % allelic shift microsatellite PCR test ) . 3 . Patient must NOT know germline mutation DNA mismatch repair gene ( MLH1 , MSH2 , MSH6 , PMS2 ) , APC , MYH gene .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Colon Cancer</keyword>
	<keyword>Rectal Cancer</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
	<keyword>Blood draw</keyword>
</DOC>